Suven Pharmaceuticals Q2 Results
- BSE: 543064
- NSE: SUVENPHAR
- ISIN: INE03QK01018
- Sector: Biotechnology & Drugs
BSE
1,275.05
-19.30 (-1.49%)
-19.30 (-1.49%)Volume18.75 K
Updated: Mon 25 Nov, 2024 | 15:29:44
NSE
1,293.9-1.25 (-0.10%)
-1.25 (-0.10%)Volume4.21 L
Updated: Mon 25 Nov, 2024 | 15:31:16
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
- Total Income₹257.72 Cr.(11.72%)
- Operating Profit₹87.05 Cr.(30.84%)
- Profit After Tax₹82.21 Cr.(35.28%)
- Operating Margin33.78%(-9.33%)
Note: Comparison is on YoY basis
Quarterly - Suven Pharmaceuticals Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 24 | Jun 23 | QoQ Comp | Sep 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 257.72 | 347.55 | -% | 231.05 | -% |
| Selling/ General/ Admin Expenses Total | 51.87 | 28.74 | -% | 28.58 | -% |
| Depreciation/ Amortization | 16.96 | 12.54 | -% | 11.89 | -% |
| Other Operating Expenses Total | 49.78 | 16.21 | -% | 13.16 | -% |
| Total Operating Expense | 170.67 | 193.13 | -% | 144.98 | -% |
| Operating Income | 87.05 | 154.42 | -% | 86.07 | -% |
| Net Income Before Taxes | 99.50 | 163.94 | -% | 105.41 | -% |
| Net Income | 82.21 | 120.59 | -% | 79.56 | -% |
| Diluted Normalized EPS | 3.21 | 4.74 | -% | 3.13 | -% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
- Markets
01NTPC Green Energy IPO allotment date likely today. GMP, how to check status online
2 min read07:58 AM IST - Markets
02Buy or sell: Sumeet Bagadia recommends three stocks to buy on Monday — Nov 25
4 min read06:15 AM IST - Markets
03Enviro Infra Engineers IPO day 2: GMP jumps; subscription status, review, apply or not?
3 min read03:07 PM IST